NDAQ:CDMO - Post Discussion
Post by
whytestocks on Mar 07, 2024 5:30pm
Biotech/Pharma Contract Service Provider Avid Bioservices Se
News; $CDMO Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance | BenzingaWednesday, Avid Bioservices Inc (NASDAQ:CDMO) reported preliminary revenues for the third quarter of fiscal 2024 of $33.8 million, repres...
CDMO - Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance | Benzinga
Be the first to comment on this post